Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
BHAC
Upturn stock ratingUpturn stock rating

Barington/Hilco Acquisition (BHAC)

Upturn stock ratingUpturn stock rating
$6
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

03/31/2025: BHAC (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Analysis of Past Performance

Type Stock
Historic Profit 1.6%
Avg. Invested days 68
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 03/31/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 70.93M USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) 43
Beta -0.07
52 Weeks Range 2.01 - 13.69
Updated Date 04/1/2025
52 Weeks Range 2.01 - 13.69
Updated Date 04/1/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.84

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -17.77%
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value 83985654
Price to Sales(TTM) -
Enterprise Value 83985654
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA -58.13
Shares Outstanding 5312120
Shares Floating 1212118
Shares Outstanding 5312120
Shares Floating 1212118
Percent Insiders 77.18
Percent Institutions 1.82

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Strong Sell -

ai summary icon Upturn AI SWOT

Barington/Hilco Acquisition

stock logo

Company Overview

History and Background

Barington/Hilco Acquisition is not a publicly traded US stock. This query lacks the proper information on its history and background to be provided

Core Business Areas

Leadership and Structure

This information is unavailable as Barington/Hilco Acquisition is not a publicly traded US stock.

Top Products and Market Share

Key Offerings

Market Dynamics

Industry Overview

This information is unavailable as Barington/Hilco Acquisition is not a publicly traded US stock.

Positioning

This information is unavailable as Barington/Hilco Acquisition is not a publicly traded US stock.

Total Addressable Market (TAM)

This information is unavailable as Barington/Hilco Acquisition is not a publicly traded US stock.

Upturn SWOT Analysis

Strengths

Weaknesses

Opportunities

Threats

Competitors and Market Share

Key Competitors

Competitive Landscape

Competitive landscape data is unavailable as Barington/Hilco Acquisition is not a publicly traded US stock.

Major Acquisitions

Growth Trajectory and Initiatives

Historical Growth: Historical growth data is unavailable as Barington/Hilco Acquisition is not a publicly traded US stock.

Future Projections: Future projection data is unavailable as Barington/Hilco Acquisition is not a publicly traded US stock.

Recent Initiatives: Recent initiative data is unavailable as Barington/Hilco Acquisition is not a publicly traded US stock.

Summary

Barington/Hilco Acquisition is not a publicly traded US stock. Thus, most data required for this analysis cannot be derived. Therefore, an accurate assessment of its overall strength and position within the US stock market cannot be provided based on the current criteria.

Similar Companies

Sources and Disclaimers

Data Sources:

  • Publicly available online search results.

Disclaimers:

The analysis is limited by the lack of publicly available information. The AI-based rating is based on incomplete data and should be interpreted with caution.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Barington/Hilco Acquisition

Exchange NASDAQ
Headquaters New York, NY, United States
IPO Launch date 2021-11-30
CEO & Director Mr. Carl M. Stanton CPA
Sector Financial Services
Industry Shell Companies
Full time employees -
Full time employees -

Focus Impact BH3 Acquisition Company does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was formerly known as Crixus BH3 Acquisition Company and changed its name to Focus Impact BH3 Acquisition Company in November 2023. Focus Impact BH3 Acquisition Company was incorporated in 2021 and is based in New York, New York. Focus Impact BH3 Acquisition Company operates as subsidiary of Focus Impact BHAC Sponsor, LLC.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​